Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study / Weichenthal, M; Ellebaek, E; Mangana, J; Asher, N; Gavrilova, I; Kandolf, L; Ugurel, S; Hausschild, A; Meier, F; Leiter, U; Livingstone, E; Gebhardt, C; Gutzmer, R; Ruhlmann, Ch; Mahncke-Guldbrandt, L; Haslund, Ca; Kopec, S; Teterycz, P; Bender, M; Poudroux, W; Muñoz-Couselo, E; Berciano-Guerrero, Ma; Shalamanova, G; Depalo, Dk; Brozić, Jm; Chiarion-Sileni, V; Arance, A; Ziogas, D; Robert, C; Van De Velde, Ao; Gassama, Aa; Shapira, R; Benbetzalel, G; Grynberg, S; Ramelyte, E; Bertoldo, F; Delprete, V; Gaudy-Marqueste, C; Mohr, P; Dummer, R; Ascierto, Pa; Gogas, H; Espinosa, E; Lebbé, C; Rutkowski, P; Haanen, J; Schadendorf, D; Svane, Im. - In: EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY. - ISSN 0277-5379. - (2025). [10.1016/j.ejca.2025.115339]

Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study

Ascierto PA;
2025

2025
Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study / Weichenthal, M; Ellebaek, E; Mangana, J; Asher, N; Gavrilova, I; Kandolf, L; Ugurel, S; Hausschild, A; Meier, F; Leiter, U; Livingstone, E; Gebhardt, C; Gutzmer, R; Ruhlmann, Ch; Mahncke-Guldbrandt, L; Haslund, Ca; Kopec, S; Teterycz, P; Bender, M; Poudroux, W; Muñoz-Couselo, E; Berciano-Guerrero, Ma; Shalamanova, G; Depalo, Dk; Brozić, Jm; Chiarion-Sileni, V; Arance, A; Ziogas, D; Robert, C; Van De Velde, Ao; Gassama, Aa; Shapira, R; Benbetzalel, G; Grynberg, S; Ramelyte, E; Bertoldo, F; Delprete, V; Gaudy-Marqueste, C; Mohr, P; Dummer, R; Ascierto, Pa; Gogas, H; Espinosa, E; Lebbé, C; Rutkowski, P; Haanen, J; Schadendorf, D; Svane, Im. - In: EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY. - ISSN 0277-5379. - (2025). [10.1016/j.ejca.2025.115339]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1017253
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact